Opioid Use Disorder Clinical Trials in San Francisco, California

4 studies are recruiting for opioid use disorder in San Francisco, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

    The purpose of this clinical trial is to compare the effectiveness of office-based methadone with pharmacy administration and/or dispensing to office-based buprenorphine for the treatment of opioid use disorder. This study will also examine factors influencing the implementation of office-based met…

    Stage
    Phase 4
    Ages
    18 to 99
    Site
    Outpatient Buprenorphine Induction Clinic, University of California, San Francisco, San Francisco, California
    Locations
    6 in total
    Run by
    Yale University

    See if you can join NCT06323824 on ClinicalTrials.gov

  2. A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder

    VA-BRAVE will determine whether a 28-day long-acting injectable sub-cutaneous formulation of buprenorphine at a target dose of 300 milligrams (mg) is superior in retaining Veterans in opioid treatment and in sustaining opioid abstinence compared to the daily sublingual (under the tongue) buprenorph…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    San Francisco VA Medical Center, San Francisco, CA, San Francisco, California
    Locations
    25 in total
    Run by
    VA Office of Research and Development

    See if you can join NCT04375033 on ClinicalTrials.gov

  3. A Study of Brenipatide in Participants With Opioid Use Disorder

    The purpose of this study is to see if brenipatide, when compared to placebo, is safe and effective for participants with opioid use disorder, when used with buprenorphine with or without naloxone. The maximum potential duration of study participation for a participant in Part A is approximately 14…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Center on Substance Use and Health (CSUH), San Francisco, California
    Locations
    59 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07420283 on ClinicalTrials.gov

  4. Using Clinical Decision Support to Provide Social Risk-Informed Care for Opioid Use Disorder in the Emergency Department

    The overarching goal of this proposal is to integrate patient social risk information into an existing electronic health record (EHR)-based clinical decision support (CDS) tool (CDSv1) to facilitate emergency department (ED)-initiated, social risk-informed opioid use disorder (OUD) medication treat…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of California, San Francisco, San Francisco, California
    Run by
    University of California, San Francisco

    See if you can join NCT06872190 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.